AI Enabled Next Generation Medical Technology Platform
A global medical technology organization was developing a next generation platform using machine vision and machine learning to evaluate biological samples within demanding clinical, regulatory, performance, cost, and physical design constraints. The AI model was only one part of the problem. The complete system also had to acquire and process high volume instrument data, support model training, manage long term storage, meet cybersecurity and regulatory requirements, integrate hardware and software, operate within physical design constraints, and achieve commercially viable performance and cost targets.
A founding team member served as Digital Systems Architect for a next generation hematology initiative at Beckman Coulter, supporting initial technical assessment, concept development, systems architecture, program development, resource planning, and engineering team formation for the multi year, multi million dollar effort. The architecture combined on device technology with AWS cloud capabilities and required decisions around AI accuracy, computation, latency, data volumes, storage, security, integration, physical design, cost, and long term supportability.
Approach
Evaluated model accuracy, computational performance, data volumes, storage strategy, architecture, and long term supportability
Helped establish the global product development organization and staff engineering teams against the development roadmap
Supported proofs of concept and development across a hybrid on device and AWS cloud architecture
Key Result
initial system architecture established
75+ people
global product development organization
7+ teams
engineering teams staffed within approximately 12 months
